Review of modelling data by Sage's Scientific Pandemic Influenza Group on Modelling (Operational) subgroup suggests later stages of UK government's roadmap out of lockdown highly likely to cause surge of covid-19 infections, BMJ
The review of data from three research groups led to warning that “unlocking “ of country “is highly likely” to lead to further resurgence in admissions and deaths, but scale, shape, and timing of potential third wave is “highly uncertain.” (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 9, 2021 Category: Consumer Health News Source Type: news
UK Covid: Johnson suggests testing for people returning from ‘green list’ countries could be simplified – as it happened
Prime minister says easyJet boss right to ask whether it would bepossible to use lateral flow tests for some returning travellers. This live blog is now closed -please follow the global coronavirus live blog for updatesEngland ’s Covid vaccine programme could slow sharply, Sage warnsNo 10 refuses to rule out Covid passports being needed to enter shopsUK ’s long Covid patients facing postcode lottery for supportWhat are Covid-status certificates and how might they work?5.32pmBSTMAIL: Call this freedom?#TomorrowsPapersTodaypic.twitter.com/NUI1LWWTiYTELEGRAPH: No end in sight as @BorisJohnson says normal is some way...
Source: Guardian Unlimited Science - April 6, 2021 Category: Science Authors: Andrew Sparrow Tags: Coronavirus Politics UK news Boris Johnson Labour Vaccines and immunisation Infectious diseases NHS Keir Starmer House of Commons Health Science Medical research Byelections Opinion polls Travel & leisure Cannabis Dru Source Type: news
Researchers Are Hatching a Low-Cost Covid-19 Vaccine
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic. (Source: NYT Health)
Source: NYT Health - April 5, 2021 Category: Consumer Health News Authors: Carl Zimmer Tags: your-feed-science Clinical Trials Coronavirus (2019-nCoV) MERS (Middle East Respiratory Syndrome) Eggs Immune System Influenza Factories and Manufacturing Antibodies Drugs (Pharmaceuticals) Biology and Biochemistry Gates, Bill and Me Source Type: news
Virus Variants Threaten to Draw Out the Pandemic, Scientists Say
Declining infection rates over all masked a rise in more contagious forms of the coronavirus. Vaccines will stop the spread, if Americans postpone celebration just a bit longer. (Source: NYT Health)
Source: NYT Health - April 3, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli and Benjamin Mueller Tags: your-feed-science Disease Rates Immune System Influenza Vaccination and Immunization Coronavirus (2019-nCoV) AstraZeneca PLC Johnson & Moderna Inc Novavax Inc Oxford University Pfizer Inc Brazil Europe Florida Germany Gre Source Type: news
Should We Keep Wearing Masks Even After the Pandemic Ends?
Riding the New York City subway during cold and flu season used to test your stomach. The woman next to you was coughing. The guy behind her was sneezing. Somebody was always fishing for a tissue.
That’s a distant memory now. The subway is far emptier, for one thing—and with the riders onboard almost universally wearing masks, the chorus of sniffles and coughs has been silenced. During the pandemic, the need for that policy is clear. But should the masks stay even after COVID-19 is gone?
Before vaccines began rolling out to the general public, masks were among the only tools available for containing SARS-CoV-2,...
Source: TIME: Health - April 2, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
Johnson & Johnson Expands Phase 2a Clinical Trial of COVID-19 Vaccine Candidate to Include Adolescents
New Brunswick, NJ (April 2, 2021) – Johnson & Johnson (the Company) has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. “The COVID-19 pandemic has had a profound impact on adolescents, not just with the complications of the disease, but with their education, mental health, and wellbeing,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson. “It is vital that we develop vaccines for everyone, everywher...
Source: Johnson and Johnson - April 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
The U.S. Death Rate Rose Significantly During the COVID-19 Pandemic
COVID-19 was the third-most-common cause of death in the U.S. in 2020, contributing to more than 375,000 deaths, and a 16% increase in the national death rate, according to provisional data published today by the U.S. Centers for Disease Control and Prevention (CDC).
All told, more than 3.3 million people in the U.S. died in 2020, for a rate of about 829 deaths per 100,000 people. That’s up from about 715 deaths per 100,000 people in 2019.
( function() {
var func = function() {
var iframe = document.getElementById('wpcom-iframe-cc2cb8dfd195b43a5d43643e9ec19ffa')
if ( iframe ) {
iframe.onload =...
Source: TIME: Health - March 31, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
Will COVID-19 vaccines need to be adapted regularly?
(Charit é - Universit ä tsmedizin Berlin) Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? Researchers from Charit é - Universit ä tsmedizin Berlin compared the evolution of endemic 'common cold' coronaviruses with that of influenza viruses. The researchers predict that, while the pandemic is ongoing, vaccines will need to undergo regular updates. A few years into the post-pandemic period, however, vaccines are likely to remain effective for longer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 25, 2021 Category: Infectious Diseases Source Type: news
Nanoparticle flu vaccine blocks seasonal and pandemic strains
(University of Washington School of Medicine/UW Medicine) Experimental flu shots have now been developed that protect animals from a wide variety of season and pandemic influenza strains. The vaccine candidate is being advanced toward clinical testing. If proven safe and effective, these next-generation influenza vaccines could replace seasonal options by protecting against more strains that current vaccines don't adequately cover. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 24, 2021 Category: Infectious Diseases Source Type: news
The Pandemic and the Limits of Science
What have we learned from the year that lasted a century? (Source: NYT Health)
Source: NYT Health - March 16, 2021 Category: Consumer Health News Authors: Alan Burdick Tags: your-feed-science Coronavirus (2019-nCoV) Science and Technology Vaccination and Immunization Epidemics your-feed-health United States Soper, George A Influenza Source Type: news
A viral tsunami: How the underestimated coronavirus took over the world
That virus would slowly reveal its secrets — and proceed to shut down much of the planet, killing more than 2.5 million people in the most disruptive global health disaster since the influenza pandemic of 1918. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - March 9, 2021 Category: Consumer Health News Authors: Joel Achenbach Source Type: news
South Africa: What South Africa Must Do to Prepare for the Third Wave Double Whammy of Covid-19 and Flu This Winter
[Daily Maverick] Pandemic preparedness for the third wave of Covid-19 must include a strong influenza prevention strategy, including vaccination. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 8, 2021 Category: African Health Source Type: news
National Academy of Medicine Launches Initiative on Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response
The National Academy of Medicine (NAM) has established an international committee (IC) in coordination with the U.S. Department of Health and Human Services ’ Office of Global Affairs (OGA) to inform and facilitate efforts to advance global influenza pandemic preparedness. (Source: News from the National Academies)
Source: News from the National Academies - March 5, 2021 Category: Science Source Type: news
